Mansour et al. postulated that possible theories might consist of the deterioration of systemic hypertension due to the stress of the intravitreal injection, an increase in intraocular pressure owing to the procedure, and the vasoconstrictor function of anti-VEGF drugs [43]. The gene discussed is VEGFA; the disease is Hypertension.